Evaluation of a modified outpatient model for using propranolol to treat infantile hemangiomas.

Vital sign monitoring may be important when starting propranolol treatment in younger or historically preterm patients. However, routine mandatory in-office vital sign monitoring may not be necessary in healthy infants more than 45 weeks postconceptional age.